DNA methylation profiling in human Huntington's disease brain

Human Molecular Genetics

Volumn 25, Issue 10, 2016, Pages 2013-2030

  De Souza, Rebecca A G ^a   Islam, Sumaiya A ^a   McEwen, Lisa M ^a   Mathelier, Anthony ^a   Hill, Austin ^a   Mah, Sarah M ^a   Wasserman, Wyeth W ^a   Kobor, Michael S ^a   Leavitt, Blair R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HUNTINGTIN; TRANSCRIPTION FACTOR CTCF; CCCTC-BINDING FACTOR; DNA BINDING PROTEIN; HTT PROTEIN, HUMAN; PROTEIN BINDING; REPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; BINDING SITE; BRAIN CORTEX; CELL HETEROGENEITY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE LOCUS; GENE SILENCING; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; MALE; MIDDLE AGED; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; ANTIBODY SPECIFICITY; CEREBELLUM CORTEX; EPIGENETICS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY;

ADULT; AGED; BINDING SITES; CEREBELLAR CORTEX; DNA METHYLATION; DNA-BINDING PROTEINS; EPIGENOMICS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HUNTINGTIN PROTEIN; HUNTINGTON DISEASE; MALE; MIDDLE AGED; ORGAN SPECIFICITY; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REPRESSOR PROTEINS;

EID: 84992206937     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddw076     Document Type: Article

References (73)

1. Pringsheim, T., Wiltshire, K., Day, L., Dykeman, J., Steeves, T. and Jette, N. (2012) The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis. Mov. Disord., 27, 1083-1091.
2. Myers, R.H. (2004) Huntington's disease genetics. Neurotherapeutics, 1, 255-262.
3. Rinaldi, C., Salvatore, E., Giordano, I., De Matteis, S., Tucci, T., Cinzia, V.R., Rossi, F., Castaldo, I., Morra, V.B., Di Maio, L. et al. (2012) Predictors of survival in a Huntington's disease population from southern Italy. Can. J. Neurol. Sci., 39, 48-51.
4. Knight, S.J.L., Flannery, A.V., Hirst, M.C., Campbell, L., Christodoulou, Z., Phelps, S.R., Pointon, J., Middleton-Price, H.R., Barnicoat, A., Pembrey, M.E. et al. (1993) Anovel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell, 72, 971-983.
5. Kremer, B., Goldberg, P., Andrew, S.E., Theilmann, J., Telenius, H., Zeisler, J., Squitieri, F., Lin, B., Bassett, A. and Almqvist, E. (1994) A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats. N. Engl. J. Med., 330, 1401-1406.
6. Rubinsztein, D.C., Leggo, J., Coles, R., Almqvist, E., Biancalana, V., Cassiman, J.J., Chotai, K., Connarty, M., Crauford, D., Curtis, A. et al. (1996) Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am. J. Hum. Genet., 59, 16-22.
7. Stine, O.C., Pleasant, N., Franz, M.L., Abbott, M.H., Folstein, S.E. and Ross, C.A. (1993) Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. Hum. Mol. Genet., 2, 1547-1549.
8. Duyao, M., Ambrose, C., Myers, R., Novelletto, A., Persichetti, F., Frontali, M., Folstein, S., Ross, C., Franz, M. and Abbott, M. (1993) Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat. Genet., 4, 387-392.
9. Wexler, N.S., Lorimer, J., Porter, J., Gomez, F., Moskowitz, C., Shackell, E., Marder, K., Penchaszadeh, G., Roberts, S.A., Gayán, J. et al. (2004) Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc. Natl Acad. Sci. USA, 101, 3498-3503.
10. Andresen, J.M., Gayán, J., Djoussé, L., Roberts, S., Brocklebank, D. and Cherny, S.S., US-Venezuela Collaborative Research Group, HD MAPS Collaborative Research Group, Cardon, L.R., Gusella, J.F. et al. (2007) The relationship between CAG repeat length and age of onset differs for Huntington's disease patients with juvenile onset or adult onset. Ann. Hum. Genet., 71, 295-301.
11. Bečanović, K., Nørremølle, A., Neal, S.J., Kay, C., Collins, J.A., Arenillas, D., Lilja, T., Gaudenzi, G., Manoharan, S., Doty, C.N. et al. (2015) A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease. Nat. Neurosci., doi:10.1038/nn.4014.
12. Van Raamsdonk, J.M., Murphy, Z., Selva, D.M., Hamidizadeh, R., Pearson, J., Petersén, A., Björkqvist, M., Muir, C., Mackenzie, I.R., Hammond, G.L. et al. (2007) Testicular degeneration in Huntington disease. Neurobiol. Dis., 26, 512-520.
13. Dixon, K.T., Cearley, J.A., Hunter, J.M. and Detloff, P.J. (2004) Mouse Huntington's disease homologmRNAlevels: variation and allele effects. Gene Expr., 11, 221-231.
14. Li, S.H., Schilling, G., Young, W.S., Li, X.J., Margolis, R.L., Stine, O.C., Wagster, M.V., Abbott, M.H., Franz, M.L. and Ranen, N.G. (1993) Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron, 11, 985-993.
15. Zuccato, C., Belyaev, N., Conforti, P., Ooi, L., Tartari, M., Papadimou, E., MacDonald, M., Fossale, E., Zeitlin, S., Buckley, N. et al. (2007)Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease. J. Neurosci., 27, 6972-6983.
16. Boutell, J.M., Thomas, P., Neal, J.W., Weston, V.J., Duce, J., Harper, P.S. and Jones, A.L. (1999) Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin. Hum. Mol. Genet., 8, 1647-1655.
17. Steffan, J.S., Kazantsev, A., Spasic-Boskovic, O., Greenwald, M., Zhu, Y.Z., Gohler, H., Wanker, E.E., Bates, G.P., Housman, D.E. and Thompson, L.M. (2000) The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc. Natl Acad. Sci. USA, 97, 6763-6768.
18. Shimohata, T., Nakajima, T., Yamada, M., Uchida, C., Onodera, O., Naruse, S., Kimura, T., Koide, R., Nozaki, K., Sano, Y. et al. (2000) Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. Nat. Genet., 26, 29-36.
19. Dunah, A.W., Jeong, H., Griffin, A., Kim, Y.-M., Standaert, D.G., Hersch, S.M., Mouradian, M.M., Young, A.B., Tanese, N. and Krainc, D. (2002) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science, 296, 2238-2243.
20. Lee, J., Hwang, Y.J., Kim, K.Y., Kowall, N.W. and Ryu, H. (2013) Epigenetic mechanisms of neurodegeneration in Huntington's disease. Neurotherapeutics, 10, 664-676.
21. Bird, A. (2007) Perceptions of epigenetics. Nature, 447, 396-398.
22. Hatchwell, E. and Greally, J.M. (2007) The potential role of epigenomic dysregulation in complex human disease. Trends Genet., 23, 588-595.
23. Jones, P.A. (2012) Functions ofDNAmethylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet., 13, 484-492.
24. Illingworth, R.S. and Bird, A.P. (2009) CpG islands-'a rough guide'. FEBS Lett., 583, 1713-1720.
25. Lam, L.L., Emberly, E., Fraser, H.B., Neumann, S.M., Chen, E., Miller, G.E. and Kobor, M.S. (2012) Factors underlying variable DNA methylation in a human community cohort. Proc. Natl Acad. Sci. USA, 109(Suppl 2), 17253-17260.
26. Gutierrez-Arcelus, M., Ongen, H., Lappalainen, T., Montgomery, S.B., Buil, A., Yurovsky, A., Bryois, J., Padioleau, I., Romano, L., Planchon, A. et al. (2015) Tissue-specific effects of genetic and epigenetic variation on gene regulation and splicing. PLoS Genet., 11, e1004958.
27. Wan, J., Oliver, V.F., Wang, G., Zhu, H., Zack, D.J., Merbs, S.L. and Qian, J. (2015) Characterization of tissue-specific differential DNA methylation suggests distinct modes of positive and negative gene expression regulation. BMC Genomics, 16, 49.
28. Farré, P., Jones, M.J., Meaney, M.J. and Emberly, E. (2015) Concordant and discordant DNA methylation signatures of aging in human blood and brain. Epigenetics Chromatin, doi:10.1186/s13072-015-0011-y.
29. Jiang, R., Jones, M.J., Chen, E., Neumann, S.M., Fraser, H.B., Miller, G.E. and Kobor, M.S. (2015) Discordance of DNA methylation variance between two accessible human tissues. Sci. Rep., 5, 8257.
30. Ng, C.W., Yildirim, F., Yap, Y.S., Dalin, S., Matthews, B.J., Velez, P.J., Labadorf, A., Housman, D.E. and Fraenkel, E. (2013) Extensive changes in DNA methylation are associated with expression of mutant huntingtin. Proc. Natl Acad. Sci. USA, 110, 2354-2359.
31. Villar-Menéndez, I., Blanch, M., Tyebji, S., Pereira-Veiga, T., Albasanz, J.L., Martín, M., Ferrer, I., Perez-Navarro, E. and Barrachina, M. (2013) Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease. Neuromolecular Med., 15, 295-309.
32. Flanagan, J.M., Popendikyte, V., Pozdniakovaite, N., Sobolev, M., Assadzadeh, A., Schumacher, A., Zangeneh, M., Lau, L., Virtanen, C., Wang, S.-C. et al. (2006) Intra-and interindividual epigenetic variation in human germ cells. Am. J. Hum. Genet., 79, 67-84.
33. Reik, W., Maher, E.R., Morrison, P.J., Harding, A.E. and Simpson, S.A. (1993) Age at onset in Huntington's disease and methylation at D4S95. J. Med. Genet., 30, 185-188.
34. Vonsattel, J.P. and DiFiglia, M. (1998) Huntington disease. J. Neuropathol. Exp. Neurol., 57, 369-384.
35. Hedreen, J.C., Peyser, C.E., Folstein, S.E. and Ross, C.A. (1991) Neuronal loss in layers Vand VI of cerebral cortex in Huntington's disease. Nerosci. Lett., 133, 257-261.
36. Reiner, A., Dragatsis, I. and Dietrich, P. (2011) Genetics and neuropathology of Huntington's disease. Int. Rev. Neurobiol., 98, 325-372.
37. Guintivano, J., Aryee, M.J. and Kaminsky, Z.A. (2013) A cell epigenotype specific model for the correction of brain cellular heterogeneity bias and its application to age, brain region and major depression. Epigenetics, 8, 290-302.
38. Jones, M.J., Islam, S.A., Edgar, R.D. and Kobor, M.S. (2015) Adjusting for cell type composition in DNA methylation data using a regression-based approach. Methods Mol. Biol., doi:10.1007/7651_2015_262.
39. Jaffe, A.E., Murakami, P., Lee, H., Leek, J.T., Fallin, M.D., Feinberg, A.P. and Irizarry, R.A. (2012) Bump hunting to identify differentially methylated regions in epigenetic epidemiology studies. Int. J. Epidemiol., 41, 200-209.
40. Horvath, S. (2013)DNA methylation age of human tissues and cell types. Genome Biol., 14, R115.
41. Hannum, G., Guinney, J., Zhao, L., Zhang, L., Hughes, G., Sadda, S., Klotzle, B., Bibikova, M., Fan, J.-B., Gao, Y. et al. (2013) Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol. Cell, 49, 359-367.
42. Jones, M.J., Goodman, S.J. and Kobor, M.S. (2015) DNA methylation and healthy human aging. Aging Cell, doi:10.1111/acel.12349.
43. Vandesompele, J. and Kubista, M. (2009) Reference gene validation software for improved normalization. Real-Time PCR: Current Technology and Applications, Vandesompele:2009to.
44. Eckhardt, F., Lewin, J., Cortese, R., Rakyan, V.K., Attwood, J., Burger, M., Burton, J., Cox, T.V., Davies, R., Down, T.A. et al. (2006) DNA methylation profiling of human chromosomes 6, 20 and 22. Nat. Genet., 38, 1378-1385.
45. Maurano, M.T., Wang, H., John, S., Shafer, A., Canfield, T., Lee, K. and Stamatoyannopoulos, J.A. (2015) Role of DNA Methylation in Modulating Transcription Factor Occupancy. Cell Rep., 12, 1184-1195.
46. Ong, C.-T. and Corces, V.G. (2014) CTCF: an architectural protein bridging genome topology and function. Nat. Rev. Genet., 15, 234-246.
47. Leavitt, B.R., Guttman, J.A., Hodgson, J.G., Kimel, G.H., Singaraja, R., Vogl, A.W. and Hayden, M.R. (2001)Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo. Am. J. Hum. Genet., 68, 313-324.
48. Vonsattel, J.P., Myers, R.H., Stevens, T.J., Ferrante, R.J., Bird, E.D. and Richardson, E.P. (1985) Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol., 44, 559-577.
49. Varley, K.E., Gertz, J., Bowling, K.M., Parker, S.L., Reddy, T.E., Pauli-Behn, F., Cross, M.K., Williams, B.A., Stamatoyannopoulos, J.A., Crawford, G.E. et al. (2013) Dynamic DNA methylation across diverse human cell lines and tissues. Genome Res., 23, 555-567.
50. Wang, H., Maurano, M.T., Qu, H., Varley, K.E., Gertz, J., Pauli, F., Lee, K., Canfield, T., Weaver, M., Sandstrom, R. et al. (2012) Widespread plasticity in CTCF occupancy linked to DNA methylation. Genome Res., 22, 1680-1688.
51. Tsai, P.-C. and Bell, J.T. (2015) Power and sample size estimation for epigenome-wide association scans to detect differential DNA methylation. Int. J. Epidemiol., doi:10.1093/ije/dyv041.
52. Bibikova, M., Barnes, B., Tsan, C., Ho, V., Klotzle, B., Le, J.M., Delano, D., Zhang, L., Schroth, G.P., Gunderson, K.L. et al. (2011) High density DNA methylation array with single CpG site resolution. Genomics, 98, 288-295.
53. Lister, R., Mukamel, E.A., Nery, J.R., Urich, M., Puddifoot, C.A., Johnson, N.D., Lucero, J., Huang, Y., Dwork, A.J., Schultz, M.D. et al. (2013) Global epigenomic reconfiguration during mammalian brain development. Science, 341, 1237905-1237905.
54. Guo, J.U., Su, Y., Shin, J.H., Shin, J., Li, H., Xie, B., Zhong, C., Hu, S., Le, T., Fan, G. et al. (2014) Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain. Nat. Neurosci., 17, 215-222.
55. Kinde, B., Gabel, H.W., Gilbert, C.S., Griffith, E.C. and Greenberg, M.E. (2015) Reading the unique DNA methylation landscape of the brain: non-CpG methylation, hydroxymethylation, and MeCP2. Proc. Natl Acad. Sci. USA, 112, 6800-6806.
56. Ulahannan, N. and Greally, J.M. (2015) Genome-wide assays that identify and quantify modified cytosines in human disease studies. Epigenetics Chromatin, 8, 5.
57. Tahiliani, M., Koh, K.P., Shen, Y., Pastor, W.A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L.M., Liu, D.R., Aravind, L. et al. (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science, 324, 930-935.
58. Wang, T., Pan, Q., Lin, L., Szulwach, K.E., Song, C.-X., He, C., Wu, H., Warren, S.T., Jin, P., Duan, R. et al. (2012) Genomewide DNA hydroxymethylation changes are associated with neurodevelopmental genes in the developing human cerebellum. Hum. Mol. Genet., 21, 5500-5510.
59. Wen, L., Li, X., Yan, L., Tan, Y., Li, R., Zhao, Y., Wang, Y., Xie, J., Zhang, Y., Song, C. et al. (2014) Whole-genome analysis of 5-hydroxymethylcytosine and 5-methylcytosine at base resolution in the human brain. Genome Biol, 15, R49.
60. Gutierrez-Arcelus, M., Lappalainen, T., Montgomery, S.B., Buil, A., Ongen, H., Yurovsky, A., Bryois, J., Giger, T., Romano, L., Planchon, A. et al. (2013) Passive and active DNA methylation and the interplay with genetic variation in gene regulation. Elife, 2, e00523.
61. Engel, N., West, A.G., Felsenfeld, G. and Bartolomei, M.S. (2004) Antagonism between DNA hypermethylation and enhancer-blocking activity at the H19 DMD is uncovered by CpG mutations. Nat. Genet., 36, 883-888.
62. Langbehn, D.R., Brinkman, R.R., Falush, D., Paulsen, J.S. and Hayden, M.R. (2004) A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin. Genet., 65, 267-277.
63. Price, M.E., Cotton, A.M., Lam, L.L., Farré, P., Emberly, E., Brown, C.J., Robinson, W.P. and Kobor, M.S. (2013) Additional annotation enhances potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 Bead-Chip array. Epigenetics Chromatin, 6, 4.
64. Du, P., Kibbe, W.A. and Lin, S.M. (2008) lumi: a pipeline for processing Illumina microarray. Bioinformatics, 24, 1547-1548.
65. Maksimovic, J., Gordon, L. and Oshlack, A. (2012) SWAN: Subset-quantile within array normalization for illumina infinium HumanMethylation450 BeadChips. Genome. Biol., 13, R44.
66. Johnson, W.E., Li, C. and Rabinovic, A. (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics, 8, 118-127.
67. Jones, M.J., Farré, P., McEwen, L.M., Macisaac, J.L., Watt, K., Neumann, S.M., Emberly, E., Cynader, M.S., Virji-Babul, N. and Kobor, M.S. (2013) Distinct DNA methylation patterns of cognitive impairment and trisomy 21 in Down syndrome. BMC Med. Genomics, 6, 58.
68. Smyth, G.K. (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol., 3, Article 3-25.
69. Orr, M. and Liu, P. (2009) Sample size estimation while controlling false discovery rate for microarray experiments using the ssize. fdr package. RJ., Orr:2009tb.
70. Du, P., Zhang, X., Huang, C.-C., Jafari, N., Kibbe, W.A., Hou, L. and Lin, S.M. (2010) Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics, 11, 587.
71. Wasserman, W.W. and Sandelin, A. (2004) Applied bioinformatics for the identification of regulatory elements. Nat. Rev. Genet., 5, 276-287.
72. Wiegreffe, C., Simon, R., Peschkes, K., Kling, C., Strehle, M., Cheng, J., Srivatsa, S., Liu, P., Jenkins, N.A., Copeland, N.G. et al. (2015) Bcl11a (Ctip1) Controls Migration of Cortical Projection Neurons through Regulation of Sema3c. Neuron, 87, 311-325.
73. Warby, S.C., Montpetit, A., Hayden, A.R., Carroll, J.B., Butland, S.L., Visscher, H., Collins, J.A., Semaka, A., Hudson, T.J. and Hayden, M.R. (2009) CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup. Am. J. Hum. Genet., 84, 351-366.